Scientists Prove Russia’s Sputnik V Vaccine 92 Percent Effective
GEALENA — Scientists Prove Russia’s Sputnik V Vaccine. Scientists yesterday gave the green light for the Russian Sputnik V vaccine. Saying it is nearly 92 percent effective against Covid-19. Based on the results of a peer-reviewed late-stage trial published in the international medical journal The Lancet.
Experts say the results of the Phase III trials mean the world has another effective weapon against the deadly pandemic. And is confirming to some extent Moscow’s decision to launch a vaccine before final data is released.
These results, compiled by the Gamaleya Institute in Moscow which developed and tested the vaccine. Are in line with efficacy data reported at an early stage of the trial, which has been running in Moscow since September.
“The development of Russia’s Sputnik V Vaccine has been criticized for its haste, shortcut, and lack of transparency,”. Said Readin University professor Ian Jones and Polly Roy, professor at the London School of Hygiene & Tropical Medicine. 3/1).
“But the results reported here are clear and the scientific principles of vaccination have been demonstrated,” said the scientists. Who was not involved in the study, in comments shared by The Lancet?
In The Lancet, researchers led by Denis Logunov of the Gamaleya Institute said the results were based on data from 19,866 volunteers. A quarter of whom received a placebo.
- Chinese Government Newspaper Removed Jack Ma from Lead Entrepreneur List
Since trials began in Moscow, there have been 16 symptomatic Covid-19 cases among people who have been vaccinated. And 62 people in the placebo group, scientists said.
This suggests that a two-sausage vaccine regimen – two shots based on two different viral vectors. Given at an interval of 21 days – is 91.6 percent effective against symptomatic Covid-19.